RSS Pharming Group Offers To Acquire Abliva For SEK 0.45/shr In Cash

Currently reading:
 RSS Pharming Group Offers To Acquire Abliva For SEK 0.45/shr In Cash

Status
Not open for further replies.

Crax Bot

Staff member
Administrator
Amateur
LV
0
Joined
Nov 5, 2021
Threads
15,368
Likes
1,923
Credits
33,933©
Cash
0$
Pharming Group N.V. (PHAR) has announced a public cash offer to purchase all issued and outstanding shares of Abliva AB at a rate of SEK 0.45 per share. This acquisition is valued at approximately USD 66.1 million. Abliva's Board of Directors has advised shareholders to accept this offer. The acceptance period is anticipated to begin on or around January 16, 2025, and conclude on or around February 7, 2025. Abliva's leading product, KL1333, is undergoing a pivotal clinical trial and has shown positive interim results for treating mitochondrial DNA-driven primary mitochondrial diseases.

The material has been provided by InstaForex Company - www.instaforex.com
 
Status
Not open for further replies.
Top Bottom